We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+0.8%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$4.76B
AUM Growth
-$301M
Cap. Flow
-$879M
Cap. Flow %
-18.47%
Top 10 Hldgs %
31.51%
Holding
169
New
40
Increased
23
Reduced
18
Closed
45

Top Buys

Rank Stock Value
1
EWTX icon
Edgewise Therapeutics
EWTX
+$128M
2
BSX icon
Boston Scientific
BSX
+$108M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$89.6M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$76M
5
TOI icon
The Oncology Institute
TOI
+$53.3M

Top Sells

Rank Stock Value
1
NKTX icon
Nkarta
NKTX
+$87.3M
2
SWTX
SpringWorks Therapeutics
SWTX
+$69.3M
3
OSH
Oak Street Health, Inc.
OSH
+$58.2M
4
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
+$56.1M
5
DFHTU
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
+$50.4M

Sector Composition

Rank Sector Weight
1 Healthcare 70.89%
2 Consumer Discretionary 0.23%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRAX icon
126
Praxis Precision Medicines
PRAX
$8.2B
– –
-23,333
Closed -$19.3M
QDEL icon
127
QuidelOrtho
QDEL
$1.13B
– –
-220,000
Closed -$39.5M
SEM
128
DELISTED
Select Medical
SEM
– –
-1,048,640
Closed -$15.6M
SRRK icon
129
Scholar Rock
SRRK
$5.94B
– –
-288,876
Closed -$14M
STTK icon
130
Shattuck Labs
STTK
$646M
– –
-550,000
Closed -$28.8M
TARA icon
131
Protara Therapeutics
TARA
$218M
– –
-782,670
Closed -$18.9M
TSHA icon
132
Taysha Gene Therapies
TSHA
$1.54B
– –
-250,000
Closed -$6.63M
VCEL icon
133
Vericel Corp
VCEL
$2.34B
– –
-64,946
Closed -$2.01M
TECX
134
Tectonic Therapeutic
TECX
$532M
– –
-66,667
Closed -$11.2M
ACCD
135
DELISTED
Accolade Inc
ACCD
– –
-638,001
Closed -$27.8M
AXNX
136
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-800,000
Closed -$39.9M
CERE
137
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-385,043
Closed -$6.38M
FUSN
138
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-162,378
Closed -$1.91M
SIEN
139
DELISTED
Sientra, Inc.
SIEN
– –
-191,812
Closed -$7.46M
VAPO
140
DELISTED
Vapotherm, Inc. Common Stock
VAPO
– –
-75,565
Closed -$16.2M
NUVA
141
DELISTED
NuVasive, Inc.
NUVA
– –
-565,000
Closed -$31.8M
OSH
142
DELISTED
Oak Street Health, Inc.
OSH
– –
-951,063
Closed -$58.2M
CDAK
143
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
– –
-450,000
Closed -$14.5M
EAR
144
DELISTED
Eargo, Inc. Common Stock
EAR
– –
-6,250
Closed -$5.6M
DFPHU
145
DELISTED
DFP Healthcare Acquisitions Corp. Unit
DFPHU
– –
-5,000,000
Closed -$56.1M
DFHTU
146
DELISTED
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
– –
-3,360,000
Closed -$50.4M
NEOS
147
DELISTED
Neos Therapeutics, Inc
NEOS
– –
-320,993
Closed -$201K
OXFD
148
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
– –
-1,049,035
Closed -$18.3M
LGVW.WS
149
DELISTED
Longview Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Clas
LGVW.WS
– –
-733,333
Closed -$4.83M
PANA.U
150
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
– –
-500,000
Closed -$6.38M
2 3 4 5
6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2021 Portfolio in Review

As of Q1 2021, Deerfield Management held 169 positions worth $4.76B, down 6% from $5.06B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Deerfield Management withdrew a net $879M in Q1 2021, closing 45 positions and reducing 18 holdings. Its most notable exit was Nkarta, an estimated $87.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 70% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Deerfield Management opened a new position in Edgewise Therapeutics worth $128M.

  • Deerfield Management's largest Q1 2021 buy was Edgewise Therapeutics: 3,933,137 shares worth $128M.
  • Deerfield Management added most to The Oncology Institute in Q1 2021, an estimated $53.3M increase.
  • Deerfield Management's biggest Q1 2021 reduction was SpringWorks Therapeutics, cutting an estimated $69.3M.
  • Deerfield Management fully exited Nkarta in Q1 2021, selling an estimated $87.3M.
  • Deerfield Management's ten largest holdings make up 32% of its $4.76B portfolio in Q1 2021.
  • Deerfield Management opened 40 new positions and closed 45 in Q1 2021.
  • Deerfield Management's portfolio value fell 6% quarter-over-quarter to $4.76B.

Based on Deerfield Management's 13F filing for Q1 2021, filed 17 May 2021.